Literature DB >> 30942491

Prehospital whole blood resuscitation prevents coagulopathy and improves acid-base status at hospital arrival in a nonhuman primate hemorrhagic shock model.

Forest R Sheppard1,2, Thomas A Mitchell3, Andrew P Cap3, Leasha J Schaub1, Antoni R Macko1, Jacob J Glaser1.   

Abstract

BACKGROUND: Hemorrhage remains the primary cause of preventable death in civilian and military trauma. The Committee on Tactical Combat Casualty Care recommends prehospital (PH) resuscitation with whole blood (WB). However, 6% hetastarch in lactated electrolyte (HEX) and crystalloids are more commonly available and used for PH resuscitation in military and civilian environments, respectively. The mechanistic benefits of PH WB resuscitation have not been well studied and remain to be elucidated. STUDY DESIGN AND METHODS: The aim of this study was to evaluate the differences in simulated PH WB and HEX resuscitation, specifically with regards to coagulation, physiologic, and metabolic outcomes to better elucidate the mechanistic benefits of WB. In a randomized study, the physiologic, coagulation, and metabolic responses to simulated PH WB (n = 12) or HEX (n = 12) were evaluated in a nonhuman primate model of severe polytraumatic hemorrhagic shock.
RESULTS: Notable findings included 1) equivalence of shock reversal between simulated PH WB and HEX treatment groups as determined by hemodynamics and base deficit and 2) prevention of coagulopathy at simulated hospital arrival with initial WB resuscitation as determined by viscoelastic and plasmatic coagulation assays.
CONCLUSION: The major benefit of WB, as compared to HEX, in simulated PH resuscitation appears to be prevention of coagulopathy at hospital arrival. Both fluids effectively reversed shock in this model, implying that efficacious provision preload (cardiac output support and hence oxygen delivery) and coagulation proteins (prevention of coagulopathy) are mechanisms underlying WB's effectiveness in early resuscitation of hemorrhagic shock.
© 2019 AABB.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30942491     DOI: 10.1111/trf.15294

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  3 in total

1.  Expired But Not Yet Dead: Examining the Red Blood Cell Storage Lesion in Extended-Storage Whole Blood.

Authors:  Kasiemobi E Pulliam; Bernadin Joseph; Rosalie A Veile; Lou Ann Friend; Amy T Makley; Charles C Caldwell; Alex B Lentsch; Michael D Goodman; Timothy A Pritts
Journal:  Shock       Date:  2021-04-01       Impact factor: 3.533

2.  Is the whole greater than the sum of its parts? The implementation and outcomes of a whole blood program in Ecuador.

Authors:  Amber Himmler; Monica Eulalia Galarza Armijos; Jeovanni Reinoso Naranjo; Sandra Gioconda Peña Patiño; Doris Sarmiento Altamirano; Nube Flores Lazo; Raul Pino Andrade; Hernán Sacoto Aguilar; Lenin Fernández de Córdova; Cecibel Cevallos Augurto; Nakul Raykar; Juan Carlos Puyana; Juan Carlos Salamea
Journal:  Trauma Surg Acute Care Open       Date:  2021-11-18

3.  Characteristics of Trauma Mortality in Patients with Aortic Injury in Harris County, Texas.

Authors:  Ronald Chang; Stacy A Drake; John B Holcomb; Garrett Phillips; Charles E Wade; Kristofer M Charlton-Ouw
Journal:  J Clin Med       Date:  2020-09-14       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.